ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,804Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 973

$815K Total Retail Price of All Prescriptions

Rank: 26 out of 973

563 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 563 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 563 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 14,039 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
POTASSIUM CHLORIDE 737 662 1 9
LEVOTHYROXINE SODIUM 715 664 2 2
OMEPRAZOLE 699 640 3 5
SIMVASTATIN 602 555 4 1
FUROSEMIDE 597 563 5 6
LISINOPRIL 420 366 6 3
METOPROLOL TARTRATE 353 310 7 13
AMLODIPINE BESYLATE 317 292 8 7
WARFARIN SODIUM 302 284 9 10
RANITIDINE HCL 288 263 10 45
ROPINIROLE HCL 260 257 11 72
HYDROCODONE-ACETAMINOPHEN 247 210 S3 12 4
PRAVASTATIN SODIUM 236 217 13 22
TAMSULOSIN HCL 217 180 14 28
METOPROLOL SUCCINATE 213 174 15 17
SERTRALINE HCL 200 150 16 21
SPIRONOLACTONE 189 151 17 49
METFORMIN HCL 187 145 18 8
CARVEDILOL 158 146 19 27
DONEPEZIL HCL 157 157 20 26
GABAPENTIN 149 113 21 12
BUMETANIDE 145 116 22 103
CARBIDOPA-LEVODOPA 142 142 23 71
ALENDRONATE SODIUM 140 137 24 24
FLUTICASONE PROPIONATE 139 109 25 35
HYDROCHLOROTHIAZIDE 134 127 26 11
DIOVAN 128 128 27 63
MELOXICAM 124 112 28 23
CLOPIDOGREL 123 119 29 44
DOXAZOSIN MESYLATE 123 110 29 87
LOSARTAN POTASSIUM 122 122 31 19
TRAMADOL HCL 117 109 32 18
POLYETHYLENE GLYCOL 3350 114 102 33 36
ADVAIR DISKUS 112 75 34 60
ATORVASTATIN CALCIUM 111 104 35 15
ALLOPURINOL 104 99 36 29
NITROGLYCERIN PATCH 99 97 37 173
CEPHALEXIN 99 93 37 75
ATENOLOL 98 97 39 16
DIOVAN HCT 97 97 40 145
NEXIUM 92 75 41 30
FLUOXETINE HCL 92 73 41 56
GLIMEPIRIDE 91 71 43 41
DILTIAZEM 24HR CD 91 91 43 104
BENAZEPRIL HCL 91 83 43 62
PLAVIX 89 88 46 78
CITALOPRAM HBR 88 84 47 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 71 48 25
NAMENDA 81 81 49 31
QUETIAPINE FUMARATE 80 75 50 70
TERAZOSIN HCL 80 78 50 112
KLOR-CON M20 77 76 52 64
TRIAMTERENE-HCTZ 76 66 53 51
ZETIA 76 74 53 81
DETROL LA 74 56 55 136
MECLIZINE HCL 74 71 55 211
CYMBALTA 73 55 57 40
PREDNISONE 68 66 58 33
DIGOXIN 68 65 58 32
SINGULAIR 68 46 58 106
ESCITALOPRAM OXALATE 67 67 61 68
FENTANYL 64 52 S2 62 53
LANTUS 63 51 63 39
LIPITOR 60 56 64 139
INSULIN SYRINGE 60 55 64 153
LEVOFLOXACIN 57 46 66 84
NOVOLOG 57 57 66 82
SOTALOL 57 57 66 178
ZOLPIDEM TARTRATE 55 55 69 20
PROAIR HFA 53 37 70 54
FINASTERIDE 53 53 70 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.